IVA Inventiva S.A. - American Depos
$3.69▲ +0.68%
Healthcare
Other
Volume 1.78M
Avg Volume (10D) 3.57M
Key Metrics & Fundamentals
Market Cap
$870.47M
P/E Ratio
–
Div Yield
0.00%
52W Range
2.82 - 7.98
% vs 50 MA
-4.96%
% vs 200 MA
-25.01%
RSI-14
55.6
MACD Histogram
+0.1100
Beta (1Y vs SPY)
0.90
Gross Rev
–
Gross Profit
–
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
–
Net Income
–
Price & Volume History
Loading chart…
Recent News

3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
MarketBeat · Oct 10, 2026 10:35 AM ET

Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026
GlobeNewswire · Oct 6, 2026 4:05 PM ET

Inventiva (IVA): How Much Is One Make-or-Break Readout Really Worth?
Insider Monkey · Oct 4, 2026 3:26 PM ET

Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Test
MarketBeat · Oct 4, 2026 1:02 AM ET
Truist Raises Price Target on Inventiva to $18 From $13, Keeps Buy Rating
MT Newswires · Oct 2, 2026 7:58 AM ET
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading
MT Newswires · Sep 29, 2026 11:07 AM ET

Inventiva (IVA) Q2 2026 Earnings Call Transcript
Motley Fool · Sep 29, 2026 10:00 AM ET

Inventiva Q2 Earnings Call Highlights
MarketBeat · Sep 28, 2026 10:02 AM ET
Sector Update: Healthcare Stocks Lean Lower Premarket Monday
MT Newswires · Sep 28, 2026 9:19 AM ET
Inventiva H1 Loss Narrows
MT Newswires · Sep 28, 2026 4:39 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.